One Forte Biosciences Insider Raised Stake By 30% In Previous Year
An insider at Forte Biosciences (NASDAQ:FBRX), CFO Antony Riley, increased his stake by 30% during the past year, purchasing shares worth US$255k at a...
An insider at Forte Biosciences (NASDAQ:FBRX), CFO Antony Riley, increased his stake by 30% during the past year, purchasing shares worth US$255k at a...
Forte Biosciences (FBRX) director David W. Gryska was granted 18,353 restricted stock units (RSUs) on May 29, 2026, which will fully vest after the co...